Full year results and review of strategic options | 25-Apr-2024 | 07:00 | RNS |
Notice of Full Year Results | 08-Apr-2024 | 07:00 | RNS |
Exercise of Options and Total Voting Rights | 19-Mar-2024 | 14:47 | RNS |
Clinical development update | 31-Jan-2024 | 07:00 | RNS |
Appointment of Nominated Adviser and Sole Broker | 22-Jan-2024 | 07:00 | RNS |
Year End Business Update | 04-Jan-2024 | 07:00 | RNS |
Grant of Share Options | 20-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 19-Oct-2023 | 07:00 | RNS |
XF Pipeline Update Meeting | 17-Oct-2023 | 07:01 | RNS |
Publication of new microbiological data for XF-73 | 17-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 10-Oct-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 04-Oct-2023 | 12:34 | RNS |
Notice of XF Pipeline Update Meeting | 27-Sep-2023 | 07:00 | RNS |
Interim Results | 20-Sep-2023 | 07:00 | RNS |
Notice of Interim Results | 23-Aug-2023 | 07:00 | RNS |